Ask the Doctor: Suicide Prevention

Finding cancer at the earliest possible stage is critical for a positive outcome. 

So, we're talking about early detection for breast cancer in tonight's Ask the Doctor, with radiologist, Dr. Kinsey Pillsbury. She's also the medical director of the Carson Tahoe Breast Center.

If you have any questions, call 858-2222 between 5 p.m. and 6 p.m. 

1)  YOUR BEST DEFENSE AGAINST BREAST CANCER IS EARLY DETECTION.  HOW SOON SHOULD WOMEN - WITH AN AVERAGE RISK OF BREAST CANCER - START BEING SCREENED? 

Carson Tahoe's comprehensive breast center offers patients the latest technological advancements - including 3D mammography, 2D mammography, breast biopsy, and breast MRI. Women's Preventative Services Initiative, or WPSI, recommends average-risk women begin mammography screening no earlier than age 40 and no later than age 50. Screening mammography should occur at least biennially and as frequently as every year. 

2)  IT'S NOT UNCOMMON TO HEAR OF WOMEN IN THEIR 30'S GETTING BREAST CANCER THESE DAYS.  WHO SHOULD GET SCREENED YOUNGER THAN 40?

3)  CARSON TAHOE BREAST CENTER IS PART OF A CLINICAL TRIAL?

Carson Tahoe Breast Center was recently selected as the only provider in Nevada, and one of only 131 worldwide, to participate in the prestigious Tomosynthesis Mammographic Imaging Screening Trial (TMIST). Led by Dr. Kinsey Pillsbury, Medical Director at Carson Tahoe Breast Center, this innovative program will offer new advancements, opportunities, and expertise in the early detection of breast cancer. "Carson Tahoe is honored to have been chosen as the only site in Nevada to participate in the Tomosynthesis Mammographic Imaging Screening Trial," says Dr. Pillsbury. "This progressive clinical trial reflects our dedication to empowering women to 'take charge of their health,' and encourages them to utilize advanced technology to detect cancer in the earliest possible stages, which is critical in supporting optimal outcomes." 

4)  ARE YOU STILL ENROLLING WOMEN?

Carson Tahoe Breast Center is actively enrolling healthy women ages 45 to 74, who are already planning to get routine mammograms, to participate in the clinical trial. By taking part in TMIST, the 165,000 registered participants will provide essential insight that will help researchers learn how to most effectively screen women for breast cancer and help them make informed decisions about the various screening opportunities available on their individual needs.